Leserbrief
Schizophrenia and Doxycycline: Microbiome Mediator?
American Journal of Psychiatry · 01.08.2026 · 183 (8) · 592-593
DOI: 10.1176/appi.ajp.20251193 ↗Kurz gefasst
Leserbrief in der Zeitschrift American Journal of Psychiatry, erschienen am 01.08.2026. Verfasst von Chika Uzoigwe. Beteiligte Einrichtung: Department of Medicine, Surgery, and Science, Harcourt House, Sheffield, United Kingdom. Die Arbeit nennt 6 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
MetabolismMolecular BiologySchizoaffective Disorder see Schizophrenia Spectrum and Other Psychotic Disorde…
Autor:innen und Institutionen
- Department of Medicine, Surgery, and Science, Harcourt House, Sheffield, United Kingdom.
Zitieren
APA
Uzoigwe, C. (2026). Schizophrenia and Doxycycline: Microbiome Mediator?. American Journal of Psychiatry, 183(8), 592-593. https://doi.org/10.1176/appi.ajp.20251193
Vancouver
Uzoigwe C. Schizophrenia and Doxycycline: Microbiome Mediator?. American Journal of Psychiatry. 2026;183(8):592-593. doi:10.1176/appi.ajp.20251193
BibTeX
@article{Uzoigwe2026,
author = {Uzoigwe, Chika},
title = {Schizophrenia and Doxycycline: Microbiome Mediator?},
journal = {American Journal of Psychiatry},
year = {2026},
volume = {183},
number = {8},
pages = {592--593},
doi = {10.1176/appi.ajp.20251193}
}
EUVIMED